Nicotine vaccine shows promise for combating tobacco addiction
A new nicotine vaccine has been developed to prevent and treat tobacco addiction by blocking nicotine from reaching the brain. The vaccine, which uses antibodies to bind to nicotine, has shown promising results in laboratory studies, reducing nicotine levels in the brain by up to 64%.